South Campus of Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
School of Health Sciences, Wuhan University, Wuhan, China.
PLoS One. 2020 Feb 13;15(2):e0228533. doi: 10.1371/journal.pone.0228533. eCollection 2020.
This systematic review and meta-analysis examines the associations of allergic rhinitis with sleep duration and sleep impairment. Observational studies published before August 2019 were obtained through English language literature searches in the PubMed, Embase, and CINAHL databases. Mean differences and odds ratios with 95% confidence intervals were extracted and used for meta-analysis. Heterogeneity was confirmed by the I2-heterogeneity test. Subgroup analysis was conducted to evaluate the influence of study design. The Grading of Recommendations Assessment, Development, and Evaluation approach was used to determine the level of evidence. In total, 2544 records were identified through database searches; 914 duplicate records were excluded, 1452 records were removed after screening of titles and abstracts, 151 records were excluded after full-text screening, and 27 articles were included in the final meta-analyses. A total of 240,706,026 patients (19,444,043 with allergic rhinitis) were considered. No significant difference in sleep duration between the allergic rhinitis and the control groups was found. Patients with allergic rhinitis presented with significantly higher sleep quality scores, sleep disturbances scores, and sleep latency scores; more frequent use of sleep medications; and lower sleep efficiency as measured by the Pittsburgh Sleep Quality Index and polysomnography. Meta-analyses for adjusted odds ratios showed that allergic rhinitis was also associated with higher risks of nocturnal dysfunctions, including insomnia, nocturnal enuresis, restless sleep, sleep-disordered breathing, obstructive sleep apnea, and snoring. Meta-analysis for adjusted odds ratio also showed that allergic rhinitis was associated with daytime dysfunction, including difficulty waking up, daytime sleepiness, morning headache, and the use of sleep medications. The overall quality of evidence ranged from low to very low, indicating that caution is required when interpreting these results. This study demonstrates that there is a significant association of AR with sleep characteristics.
本系统评价和荟萃分析研究了变应性鼻炎与睡眠时间和睡眠障碍的关系。通过在 PubMed、Embase 和 CINAHL 数据库中进行英语文献检索,获得了发表于 2019 年 8 月之前的观察性研究。提取并使用均值差和 95%置信区间的比值比进行荟萃分析。通过 I2 异质性检验确认异质性。进行亚组分析以评估研究设计的影响。使用推荐评估、制定与评价(Grading of Recommendations Assessment, Development, and Evaluation,GRADE)方法确定证据水平。通过数据库检索共确定了 2544 条记录;排除了 914 条重复记录,在标题和摘要筛选后排除了 1452 条记录,在全文筛选后排除了 151 条记录,最终有 27 篇文章纳入荟萃分析。共考虑了 240706026 名患者(19444043 名患有变应性鼻炎)。过敏性鼻炎组和对照组之间的睡眠时间无显著差异。患有过敏性鼻炎的患者睡眠质量评分、睡眠障碍评分和入睡潜伏期评分更高;更频繁地使用睡眠药物;匹兹堡睡眠质量指数和多导睡眠图测量的睡眠效率更低。调整后的比值比荟萃分析显示,过敏性鼻炎还与夜间功能障碍(包括失眠、夜间遗尿、不安睡眠、睡眠呼吸障碍、阻塞性睡眠呼吸暂停和打鼾)的风险增加相关。调整后的比值比荟萃分析还显示,过敏性鼻炎与日间功能障碍(包括难以醒来、日间嗜睡、晨头痛和使用睡眠药物)相关。总体证据质量从低到极低不等,表明在解释这些结果时需要谨慎。本研究表明,AR 与睡眠特征有显著关联。